The Food and Drug Administration (FDA) announced it will require makers of fast-acting opioids to fund voluntary training for healthcare professionals who prescribe the drugs, according to Reuters.

The training will include education on safe prescribing practices and non-opioid alternatives.

The FDA informed 74 manufacturers of immediate-release opioids that they will have to fund training for doctors, nurses and pharmacists.

Companies that make extended-release and long-acting formulations of opioids already must pay for training of healthcare professionals. The FDA is also considering some type of mandatory education on opioids, the article notes.

According to the FDA, approximately 160 million prescriptions a year – about 90 percent of all opioid pain medications prescribed in the United States – are for fast-acting formulations.